Digitalis × fulva Digitalis × fulva Digitalis" × "fulva, the strawberry foxglove, is a fertile hybrid between "Digitalis grandiflora" and "Digitalis purpurea". This perennial herbaceous plant reaches on average a height of . The erect stems rise from a semi-evergreen basal rosette of soft leaves. It has typical tall spikes of large tubular flowers. The color ranges from strawberry pink (hence the common name) to mauve. The flowering period extends from late spring to early summer. It prefers neutral or mildly acidic substrate and rich, moist and regularly watered soil, in full sun or in partial shade. This plant, which is widely marketed
New Drug Application Review should complete within 6 months. The decision comes in a "Complete Response Letter". Biologics, such as vaccines and many recombinant proteins used in medical treatments are generally approved by FDA via a Biologic License Application (BLA), rather than an NDA. The manufacture of biologics is considered to differ fundamentally from that of less complex chemicals, requiring a somewhat different approval process. Generic drugs that have already been approved via an NDA submitted by another maker are approved via an Abbreviated New Drug Application (ANDA), which does not require all of the clinical trials normally required for a new drug